Ranjan (Ron) Batra, Ph.D.
Vice President of Research and Development, Locana, Inc.
Ranjan (Ron) Batra is the vice president of research and development at Locana, Inc. where he is involved in creating and deploying RNA targeting gene therapy for various genetic diseases. Ron graduated from the Ph.D. program in molecular genetics at University of Florida, where he worked on RNA mediated disorders. Further, Ron did his postdoctoral training at Mayo Clinic and subsequently at University of California, San Diego.
Ron was awarded the myotonic dystrophy foundation (MDF) postdoctoral fellowship for his work at UC San Diego where he co-developed RNA targeting CRISPR therapeutics platform which was published in Cell in 2017. Briefly, Ron worked at Verily (formerly Google Life Sciences) before joining Locana in 2018. Locana received the Venture Philanthropy (MVP) grant from the Muscular Dystrophy Association for which Ron is the principal investigator. “I’m committed to working with and training the next generation of students and biotech scientists in pursuit of therapies for incurable genetic diseases.